CN110452115A - A kind of synthetic method of poly 3-hydroxy butyrate quasi-oligomer and its obtained product and purposes - Google Patents

A kind of synthetic method of poly 3-hydroxy butyrate quasi-oligomer and its obtained product and purposes Download PDF

Info

Publication number
CN110452115A
CN110452115A CN201810431506.6A CN201810431506A CN110452115A CN 110452115 A CN110452115 A CN 110452115A CN 201810431506 A CN201810431506 A CN 201810431506A CN 110452115 A CN110452115 A CN 110452115A
Authority
CN
China
Prior art keywords
oligomer
formula
poly
synthetic method
quasi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810431506.6A
Other languages
Chinese (zh)
Other versions
CN110452115B (en
Inventor
陶肖明
李俊
张子恒
杨兴兴
马琳琳
刘世瑞
费宾
梁杏媚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HONG KONG RES INST OF TEXTILES (HK)
Original Assignee
HONG KONG RES INST OF TEXTILES (HK)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HONG KONG RES INST OF TEXTILES (HK) filed Critical HONG KONG RES INST OF TEXTILES (HK)
Priority to CN201810431506.6A priority Critical patent/CN110452115B/en
Publication of CN110452115A publication Critical patent/CN110452115A/en
Application granted granted Critical
Publication of CN110452115B publication Critical patent/CN110452115B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/06Unsaturated carboxylic acids or thio analogues thereof; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/533Monocarboxylic acid esters having only one carbon-to-carbon double bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The present invention provides a kind of synthetic methods of poly 3-hydroxy butyrate quasi-oligomer, using lactone as raw material, at aluminum alkoxide Al (OR)3The oligomer is made with reaction in the presence of pyridine.The present invention also provides a kind of poly 3-hydroxy butyrate quasi-oligomer and its preparing the purposes in anti-biotic material.The lower poly 3-hydroxy butyrate quasi-oligomer of molecular weight can be made in synthetic method provided by the invention, which has excellent and stablize lasting antibacterial activity, be highly suitable as anti-biotic material.Synthesising method reacting condition of the invention is mild, and purifying process also greatly simplifies, and is suitable for industrialized production and large-scale use.

Description

A kind of synthetic method of poly 3-hydroxy butyrate quasi-oligomer and its obtained product and Purposes
Technical field
The present invention relates to chemosynthesis technical fields, and in particular to a kind of synthesis side of poly 3-hydroxy butyrate quasi-oligomer Method, thus obtained oligomer product and its purposes.
Background technique
Poly 3-hydroxy butyrate (PHB) is a kind of biodegradable plastic generated by microbial fermentation, as a kind of micro- The nutrition of biology and ergastic substances, PHB have excellent biocompatibility, and catabolite also belongs to human body natural component, because The characteristic of its nontoxic residue-free is widely used in the fields such as weaving, food packaging, drug release, tissue engineering bracket.
High molecular weight PHB mainly passes through microbial fermentation (biochemical method) and chemical synthesis obtains.Biochemical method native annulus It protects, it is safe and non-toxic, but the production cycle is long, purification and high process cost can be greatly lowered into using chemical synthesis This, and its bioactivity will not change.Since 3-hydroxybutyrate is by thermally labile, chemical synthesis is often with beta-butyrolactone Monomer, alkyl or metal alkoxides complex are catalyst, and it is tens of thousands of to hundreds of thousands of to prepare molecular weight by the method for ring-opening polymerisation PHB.
About the degree of polymerization lower than 100, even lower than 20 oligomerization PHB, also have been reported that it has prevention sclerotin and dredges in recent years Loose isoreactivity, but for preparation method, more or PHB using high molecular weight is made by hydrolysis or enzymatic hydrolysis.
Summary of the invention
To overcome limitation existing for oligomerization PHB preparation method in the prior art, an object of the present invention is to provide one The synthetic method of kind poly 3-hydroxy butyrate quasi-oligomer.
It is a further object of the present invention to provide a kind of poly 3-hydroxy butyrate quasi-oligomers.
A further object of the invention is to provide the purposes of the poly 3-hydroxy butyrate quasi-oligomer.
A further object of the invention is to provide a kind of bio-based materials with antibacterial action.
The present invention provides the synthetic methods of one kind poly 3-hydroxy butyrate quasi-oligomer as shown in formula (1), with formula (2) Shown in lactone be raw material, at aluminum alkoxide Al (OR)3The oligomer is made with reaction in the presence of pyridine,
In formula (1) and formula (2), R ' indicates hydrogen or C1~C5Alkyl, R indicate C1~C5Alkyl, m indicate 0~3 it is whole Number, n indicate 1~20 integer.
Reaction route are as follows:
In existing PHB quasi polymer synthetic technology, use the lactone compounds such as beta-butyrolactone for raw material, aluminum alkoxide Chemical synthesis process as catalyst has the following deficiencies: that (1) reaction raw materials need to be handled by stringent anhydrous and oxygen-free, and is catalyzed Agent needs are slowly added dropwise among reaction system, and operation requires harsh;(2) reaction process needs higher temperature and longer anti- Between seasonable;(3) for oligomer molecules amount made from generally in 2000-5000, the end group of reaction product is alkyl and hydroxyl;(4) anti- The aluminium salt for answering system to generate is difficult to be removed, and excess EDTA solution need to be used to wash repeatedly, purification process is cumbersome.
Present inventor have discovered that carrying out open loop in the presence of aluminum alkoxide and common pyridine using lactone compound as raw material It polymerize changeable above situation, the lower oligomer of molecular weight can be made, exists without solvent, reaction process is without height Temperature is reacted for a long time, and method of purification can also significantly simplify.The addition for being presumably due to pyridine can be coordinated to destroy with aluminium The tetramer structure of aluminum alkoxide, to reduce reaction temperature, improve reaction rate, the molecular weight of resulting polymers also can Enough control is in lower level, moreover, pyridine itself also can be used as reaction medium.
In poly 3-hydroxy butyrate quasi-oligomer made from synthetic method of the present invention, end group is respectively alkoxy and double bond, Alkoxy derives from aluminum alkoxide, and it is obtained by hydroxyls dehydrate that double bond, which then speculates,.
In synthetic method provided by the invention, oligomer shown in formula (1) is preferably few poly 3-hydroxy butyrate, and number is equal Molecular weight can be 1000 or less.
In synthetic method provided by the invention, the aluminum alkoxide Al (OR)3It can be used in being catalyzed β-to be existing The all kinds of butyrolactone ring-opening polymerisation preferably can be the aluminum alkoxide of low alkyl group, and more preferable R is the alkyl of C1~C5, Including but not limited to methyl, ethyl, propyl, isopropyl, normal-butyl, isobutyl group, sec-butyl, tert-butyl etc..
In synthetic method provided by the invention, pyridine, which also can be replaced, can be coordinated with aluminium and have certain weakly alkaline pyridine Analog.
In synthetic method provided by the invention, the aluminum alkoxide Al (OR)3Mole dosage ratio with pyridine can be 1 ﹕ 1 ~5;It is preferred that can be 1 ﹕ 1~2.
In synthetic method provided by the invention, the aluminum alkoxide Al (OR)3With the mole dosage of lactone shown in formula (2) It preferably can be 1 ﹕ 10~30 than that can be 1 ﹕ 10~50.
In synthetic method provided by the invention, the ring-opening polymerization of lactone can carry out at lower temperature, when reaction Between can also be obviously shortened, can be adjusted by those skilled in the art according to response situation;It is preferred that can be that will react on 30~60 DEG C It is lower to carry out 10~40 hours;It can more preferably be carried out 20~30 hours for that will react at 40~60 DEG C.
In synthetic method provided by the invention, reaction system generation can be removed using dilute acid soln washing after completion of the reaction Aluminium salt.Wherein, dilute acid soln can be able to be 1~5M for solution, molar concentrations such as common dilute hydrochloric acid, dilute sulfuric acids.
Shown in poly 3-hydroxy butyrate quasi-oligomer provided by the invention such as formula (1),
The definition of each group is identical as aforementioned definitions in formula (1).
It is preferable to use the described in any item synthetic methods of preceding solution to be made for oligomer provided by the invention.
Oligomer provided by the invention is preferably widow's poly 3-hydroxy butyrate shown in formula (3),
In formula (3), n is preferably represented by 1~6 integer.
The number-average molecular weight of widow's poly 3-hydroxy butyrate provided by the invention can be 1000 or less.
It is (including oligomeric shown in formula (1) and formula (3) that the present invention also provides the poly 3-hydroxy butyrate quasi-oligomers Object) preparing the purposes in anti-biotic material.
Present inventor have discovered that have very excellent antibacterial activity using oligomer made from synthetic method of the invention, > 99.99% can reach for the antibacterial effect of staphylococcus aureus, pneumobacillus, Candida albicans, there is broad-spectrum antiseptic Effect.Thus poly 3-hydroxy butyrate quasi-oligomer product of the invention is particularly suitable for preparing anti-biotic material.
Anti-biotic material of the present invention can be any form or type, as long as can be low by poly 3-hydroxy butyrate class Polymers (including oligomer shown in formula (1) and formula (3)) applies in anti-biotic material as Antibacterial Constituents, and does not influence to live The antibacterial activity of property ingredient.Including but not limited to antibiotic preparation, antibiotic fabric, amenities, medical material etc., it is especially suitable For weaving, the fields such as health care.Such as combinable or modified existing polymer textiles, then for example for antibiotic preparation, It may be used as the preparations such as drug, disinfectant, in another example being used for medical material, can be used for wound covering material, dressing, operation stitching Line, implantation material, pharmaceutical carrier and other biological medical material.Anti-biotic material of the present invention can be used alone, can also It is used in combination with other antibiotic preparations, anti-biotic material, can also be used to be modified or be transformed other anti-biotic materials.
The present invention also provides a kind of bio-based materials with antibacterial action, uses and gather described in above technical scheme 3-hydroxybutyrate oligoesters (including oligomer shown in formula (1) and formula (3)) is used as Antibacterial Constituents.
In bio-based materials of the present invention with antibacterial action, except using poly 3-hydroxy butyrate quasi-oligomer to make Except active constituent, any adding ingredient outside active constituent that can also use comprising existing anti-biotic material, added material, Auxiliary substance etc. as long as active constituent can be made to the anti-biotic material of arbitrary form or type, and does not influence active constituent Antibacterial activity, the present invention is with no restrictions.
The lower poly- 3- of molecular weight can be made in the synthetic method of poly 3-hydroxy butyrate quasi-oligomer provided by the invention Hydroxybutyric acid oligoesters, obtained oligomer have excellent and stablize lasting antibacterial activity, all to various bacteria, fungi Have significant antibacterial effect, but also there are the performances such as excellent biodegradability, biocompatibility, is highly suitable as Anti-biotic material, the especially fields such as weaving, health care anti-biotic material.
Synthesising method reacting condition of the invention is mild, and the raw material used needs not move through anhydrous and oxygen-free processing, without making With solvent, reaction temperature be can obviously reduce, and the reaction time can also be obviously shortened, and purifying process after completion of the reaction is also significantly simple Change, target product yield is high.In terms of comprehensive, production cost can be greatly reduced in synthetic method of the invention, improve production process Safety is highly suitable for industrialized production and large-scale use.
Detailed description of the invention
Fig. 1 is the nucleus magnetic hydrogen spectrum figure of widow's poly 3-hydroxy butyrate made from embodiment;
Fig. 2 is the nuclear-magnetism carbon spectrogram of widow's poly 3-hydroxy butyrate made from embodiment;
Fig. 3 is the High Performance Liquid Chromatography/Mass Spectrometry figure of widow's poly 3-hydroxy butyrate made from embodiment;
Fig. 4 is the infrared spectrogram of widow's poly 3-hydroxy butyrate made from embodiment.
Specific embodiment
To make the object, technical solutions and advantages of the present invention clearer, it will be further described below example of the invention The technical solution of property embodiment.
Chemical reagent used in following embodiment is then unless otherwise instructed commercial goods, used in following embodiment Operation or instrument are then this field common operation or instrument unless otherwise instructed.
Embodiment
Aluminum isopropoxide 0.61g (3mmol), pyridine 2.5mL and beta-butyrolactone 5.2g (60mmol) are added in the reactor, 50 DEG C of reactions under conditions of nitrogen protection.After reaction about 15 minutes, reaction solution is in glassy yellow, greening after a period of time, later Color is gradually deepened, and reaction became sepia after 24 hours.Reaction terminates after being cooled to room temperature, and 20mL 2M is added in reaction solution In dilute hydrochloric acid, stir a period of time after with 20mL methylene chloride extraction three times, merge organic layer, successively with dilute hydrochloric acid (20mL × 2), 2M solution of potassium carbonate (20mL × 1) and deionized water (20mL × 2) wash organic layer.It depressurizes and steams after anhydrous sodium sulfate is dry Distillation goes solvent to obtain yellow oil.Gained grease quickly rushes column purification with methylene chloride, after vacuum distillation removes solvent 50 DEG C are dried in vacuum overnight, and obtain light yellow oil 4.0g, yield 77%.
Appropriate above-mentioned product is taken to be dissolved in deuterated chloroform (CDCl3) in, oligomerization 3-hydroxybutyrate is obtained by nuclear magnetic resonance The nucleus magnetic hydrogen spectrum (as shown in Figure 1) and carbon of ester compose (as shown in Figure 2).
Appropriate above-mentioned product is taken to be dissolved in 1:1 methylene chloride/methanol mixed solution, 0.45 μm of filtering with microporous membrane leads to It crosses high performance liquid chromatography-mass spectrograph and obtains High Performance Liquid Chromatography/Mass Spectrometry (HPLC-MS) figure (such as Fig. 3 of few poly 3-hydroxy butyrate It is shown).
Appropriate above-mentioned product is taken to obtain the infrared figure (as shown in Figure 4) of few poly 3-hydroxy butyrate by infrared spectrometer.
By nucleus magnetic hydrogen spectrum (1H NMR), nuclear-magnetism carbon spectrum (13C NMR), High Performance Liquid Chromatography/Mass Spectrometry (HPLC-MS) and Infrared spectroscopy (IR) is characterized, and determines its structure are as follows:
The peak M+1 that corresponding polymerization degree n is 1-6 can be found by LC-MS spectrogram, therefore the n in the structural formula is 1-6.
Experimental example
Widow's poly 3-hydroxy butyrate made from embodiment is diluted to 20mg/mL with phosphate buffer (PBS), shakes method (referring to national standard method GB-T20944.3-2008) detects its antibacterial activity, and PBS group does blank control.Gained anti-microbial property The results are shown in Table 1.
Table 1
As seen from the results in Table 1: widow's poly 3-hydroxy butyrate is to staphylococcus aureus, lung made from synthetic method of the present invention The various bacterias such as scorching bacillus, Candida albicans, fungi all have efficient antibacterial action, and antibacterial effect can reach > 99.99%, But also has the effect of broad-spectrum antiseptic.
Few poly 3-hydroxy butyrate is repeated as many times above-mentioned experiment, each experimental result is shown greater than 99.99% Antibacterial activity.It places at room temperature and half a year and then detects antibacterial activity as procedure described above, still be able to have and be greater than 99.99% antibacterial activity, it is seen that its property is stablized, and antibacterial activity is stable and lasting.
Although the preferred embodiments of the invention, those skilled in the art has been disclosed in order to illustrate the present invention Member can be the present invention it should be appreciated that in the case where not departing from present inventive concept defined by claims and range Various modifications, addition and replacement out.

Claims (11)

1. a kind of synthetic method of the poly 3-hydroxy butyrate quasi-oligomer as shown in formula (1), is original with lactone shown in formula (2) Material, at aluminum alkoxide Al (OR)3The oligomer is made with reaction in the presence of pyridine,
In formula (1) and formula (2), R ' indicates hydrogen or C1~C5Alkyl, R indicate C1~C5Alkyl, m indicate 0~3 integer, n table Show 1~20 integer.
2. synthetic method according to claim 1, which is characterized in that oligomer shown in the formula (1) is oligomerization 3- hydroxyl Base butyrate, number-average molecular weight are 1000 or less.
3. synthetic method according to claim 1 or 2, which is characterized in that the aluminum alkoxide Al (OR)3With rubbing for pyridine Your amount ratio is 1 ﹕ 1~5.
4. synthetic method according to claim 1-3, which is characterized in that the aluminum alkoxide Al (OR)3And formula (2) the mole dosage ratio of lactone shown in is 1 ﹕ 10~50.
5. synthetic method according to claim 1-4, which is characterized in that react at 30~60 DEG C carry out 10~ 40 hours.
6. synthetic method according to claim 5, which is characterized in that use dilute acid soln washing to remove after completion of the reaction The aluminium salt that reaction system generates.
7. a kind of poly 3-hydroxy butyrate quasi-oligomer as shown in formula (1),
In formula (1), R ' indicates hydrogen or C1~C5Alkyl, R indicate C1~C5Alkyl, m indicate 0~3 integer, n indicate 1~20 Integer.
8. oligomer according to claim 7, which is characterized in that the oligomer is oligomerization 3- hydroxyl shown in formula (3) Butyrate,
In formula (3), n indicates 1~6 integer.
9. poly 3-hydroxy butyrate quasi-oligomer described in claim 7 or 8 is preparing the purposes in anti-biotic material.
10. purposes according to claim 9, which is characterized in that the anti-biotic material is antibiotic preparation, antibiotic fabric, defends One of raw articles, medical material are a variety of.
11. a kind of bio-based materials with antibacterial action, which is characterized in that including poly- 3- hydroxyl described in claim 7 or 8 Butyric acid ester oligomer is as Antibacterial Constituents.
CN201810431506.6A 2018-05-08 2018-05-08 Synthesis method of poly 3-hydroxybutyrate oligomer, product obtained by synthesis method and application of oligomer Active CN110452115B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810431506.6A CN110452115B (en) 2018-05-08 2018-05-08 Synthesis method of poly 3-hydroxybutyrate oligomer, product obtained by synthesis method and application of oligomer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810431506.6A CN110452115B (en) 2018-05-08 2018-05-08 Synthesis method of poly 3-hydroxybutyrate oligomer, product obtained by synthesis method and application of oligomer

Publications (2)

Publication Number Publication Date
CN110452115A true CN110452115A (en) 2019-11-15
CN110452115B CN110452115B (en) 2022-04-29

Family

ID=68480392

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810431506.6A Active CN110452115B (en) 2018-05-08 2018-05-08 Synthesis method of poly 3-hydroxybutyrate oligomer, product obtained by synthesis method and application of oligomer

Country Status (1)

Country Link
CN (1) CN110452115B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113200849A (en) * 2021-04-27 2021-08-03 香港理工大学 Separation and purification method of synthesized 3-hydroxybutyrate oligomer or oligomer and application of synthesized 3-hydroxybutyrate oligomer or oligomer in antibacterial and antiviral products
EP3988536A1 (en) 2020-10-26 2022-04-27 Zhejiang Enmat Biological Technology Co., Ltd. Efficient anti-bacterial hydroxy acid ester oligomer
CN115821426A (en) * 2022-12-16 2023-03-21 扬州富威尔复合材料有限公司 Crystalline bio-based low-melting-point polyester composite fiber with antibacterial function and preparation method thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101160342A (en) * 2005-04-12 2008-04-09 巴斯福股份公司 Method for producing polyhydroxyalkanoates
US20110250539A1 (en) * 2010-04-07 2011-10-13 Masayoshi Sagehashi Fluorinated monomer, polymer, resist composition, and patterning process
CN102482404A (en) * 2009-09-03 2012-05-30 Co2斯塔奇私人有限公司 Polymer/thermoplastic starch compositions
US20120232185A1 (en) * 2011-03-10 2012-09-13 Yuan Ze University Biodegradable polymer and method for manufacturing the same
CN103483562A (en) * 2013-09-26 2014-01-01 南京年吉冷冻食品有限公司 Chemical synthesis method for polyhydroxybutyrate
US20140199631A1 (en) * 2013-01-15 2014-07-17 Shin-Etsu Chemical Co., Ltd. Monomer, polymer, resist composition, and patterning process
CN105717744A (en) * 2014-12-18 2016-06-29 信越化学工业株式会社 Monomer, Polymer, Resist Composition, And Patterning Process

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101160342A (en) * 2005-04-12 2008-04-09 巴斯福股份公司 Method for producing polyhydroxyalkanoates
CN102482404A (en) * 2009-09-03 2012-05-30 Co2斯塔奇私人有限公司 Polymer/thermoplastic starch compositions
US20110250539A1 (en) * 2010-04-07 2011-10-13 Masayoshi Sagehashi Fluorinated monomer, polymer, resist composition, and patterning process
US20120232185A1 (en) * 2011-03-10 2012-09-13 Yuan Ze University Biodegradable polymer and method for manufacturing the same
US20140199631A1 (en) * 2013-01-15 2014-07-17 Shin-Etsu Chemical Co., Ltd. Monomer, polymer, resist composition, and patterning process
CN103483562A (en) * 2013-09-26 2014-01-01 南京年吉冷冻食品有限公司 Chemical synthesis method for polyhydroxybutyrate
CN105717744A (en) * 2014-12-18 2016-06-29 信越化学工业株式会社 Monomer, Polymer, Resist Composition, And Patterning Process

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3988536A1 (en) 2020-10-26 2022-04-27 Zhejiang Enmat Biological Technology Co., Ltd. Efficient anti-bacterial hydroxy acid ester oligomer
WO2022088286A1 (en) * 2020-10-26 2022-05-05 浙江英玛特生物科技有限公司 Water-soluble controllable antibacterial substance and synthesis process
EP4292590A2 (en) 2020-10-26 2023-12-20 Zhejiang Enmat Biological Technology Co., Ltd. Efficient anti-bacterial hydroxy acid ester oligomer
EP4292590A3 (en) * 2020-10-26 2024-03-13 Nanjing Bioserica Era Biological Technology Co., Ltd. Efficient anti-bacterial hydroxy acid ester oligomer
CN113200849A (en) * 2021-04-27 2021-08-03 香港理工大学 Separation and purification method of synthesized 3-hydroxybutyrate oligomer or oligomer and application of synthesized 3-hydroxybutyrate oligomer or oligomer in antibacterial and antiviral products
CN115821426A (en) * 2022-12-16 2023-03-21 扬州富威尔复合材料有限公司 Crystalline bio-based low-melting-point polyester composite fiber with antibacterial function and preparation method thereof
CN115821426B (en) * 2022-12-16 2024-04-26 扬州富威尔复合材料有限公司 Crystalline bio-based low-melting-point polyester composite fiber with antibacterial function and preparation method thereof

Also Published As

Publication number Publication date
CN110452115B (en) 2022-04-29

Similar Documents

Publication Publication Date Title
CN110452115A (en) A kind of synthetic method of poly 3-hydroxy butyrate quasi-oligomer and its obtained product and purposes
EP2264020B1 (en) Catalyst for direct conversion of esters of lactic acid to lactide and the method for producing lactide using the same
CN106397389B (en) A kind of process synthesizing glycolide
CN116178159A (en) Efficient antibacterial hydroxy acid ester oligomer
CN106928068B (en) A kind of tetracyclic diterpene class iso steviol compound and the preparation method and application thereof
Lee et al. Efficient one-pot synthesis of benzopyranobenzopyrans and naphthopyranobenzopyrans by domino aldol-type reaction/hetero Diels–Alder reaction of resorcinols and naphthols
CN110563941B (en) Preparation method of medical biodegradable high polymer material polycaprolactone
CN111269402B (en) Method for catalyzing lactide polymerization by using asymmetric binuclear amine imine aluminum complex
US20110009593A1 (en) Polymeric Bioplastics
CN104497280B (en) A kind of preparation method of PGA
CN103819429A (en) Preparation method and application of amino polycarboxylic acid modified paclitaxel compound
KR101183982B1 (en) Process for preparing lactide and polylactide from Lactic acid fermentation
CN101215374B (en) Preparation of cyclic esters ring-opening polymerization catalyst phosphoric acid creatinine guanidine
CN110590728A (en) Synthesis method of polysubstituted 4-phenyl chroman compounds
CN111154088B (en) Method for catalyzing polymerization of glycolide by using asymmetric binuclear amine imine aluminum complex
CN103833662B (en) Benzoxazoles amphyl, the aluminum complex and its preparation method and application of this derivative
CN111165504B (en) Application of sesquiterpenoids and derivatives thereof in preparation of medicines for preventing and treating wheat scab
JPH0710234B2 (en) Method for producing lactone
CN111378099B (en) Method for catalyzing caprolactone polymerization by using asymmetric binuclear amine imine aluminum complex
CN115521278B (en) Preparation method of benzofuranone derivative
CN109438486B (en) Amine imine magnesium complex and preparation method and application thereof
CN107164423A (en) A kind of method that whole-cell catalytic prepares Troxerutin ester
CN115124633B (en) Preparation method and application of thymol composition
CN113200849A (en) Separation and purification method of synthesized 3-hydroxybutyrate oligomer or oligomer and application of synthesized 3-hydroxybutyrate oligomer or oligomer in antibacterial and antiviral products
CN108853078B (en) Preparation method of antibacterial drug

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant